Vanguard Amends Pfizer Stake: SC 13G/A Filed Feb 13, 2024

Ticker: PFE · Form: SC 13G/A · Filed: 2024-02-13T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

Related Tickers: PFE

TL;DR

**Vanguard updated its Pfizer ownership, confirming its continued large stake.**

AI Summary

The Vanguard Group, a major investment firm, filed an amendment to its Schedule 13G on February 13, 2024, indicating its beneficial ownership of Pfizer Inc. common stock as of December 29, 2023. This filing, Amendment No. 9, updates Vanguard's stake in Pfizer, a pharmaceutical giant (CIK: 0000078003). For investors, this matters because Vanguard is a significant institutional holder, and changes in its reported ownership can signal shifts in large-scale investor sentiment or portfolio adjustments, potentially influencing market perception of Pfizer's stock.

Why It Matters

This filing shows that Vanguard Group continues to be a significant institutional investor in Pfizer, providing transparency into major ownership stakes which can influence market sentiment.

Risk Assessment

Risk Level: low — This is a routine amendment filing by a large institutional investor, indicating no immediate or significant new risks.

Analyst Insight

Investors should note that Vanguard, a major institutional investor, continues to hold a significant stake in Pfizer. While this specific filing is an update and doesn't reveal a new position, it reinforces Vanguard's long-term interest. Smart investors might monitor future 13G/A filings from Vanguard for any substantial changes in their reported ownership percentage, which could signal a shift in their investment thesis for Pfizer.

Key Players & Entities

FAQ

What type of filing is this document and what does it signify?

This document is an SC 13G/A, which is an amendment to a Schedule 13G. It signifies that The Vanguard Group is updating its previously reported beneficial ownership of Pfizer Inc. common stock, as required by the Securities Exchange Act of 1934.

Who is the reporting person in this filing?

The reporting person in this filing is The Vanguard Group, identified with IRS Identification No. 23-1945930 and organized in Pennsylvania.

What is the subject company whose securities are being reported?

The subject company is Pfizer Inc., with CIK 0000078003, and the title of the class of securities is Common Stock with CUSIP Number 717081103.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023, as stated in the filing.

Under which rule of the Securities Exchange Act of 1934 is this Schedule 13G/A filed?

This Schedule 13G/A is filed under Rule 13d-1(b) of the Securities Exchange Act of 1934, as indicated by the checked box in the filing.

From the Filing

0001104659-24-021706.txt : 20240213 0001104659-24-021706.hdr.sgml : 20240213 20240213171207 ACCESSION NUMBER: 0001104659-24-021706 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60005 FILM NUMBER: 24629267 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD GROUP INC CENTRAL INDEX KEY: 0000102909 ORGANIZATION NAME: IRS NUMBER: 231945930 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 SC 13G/A 1 tv01692-pfizerinc.htm SCHEDULE 13G/A pfizerinc SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer:  Pfizer Inc Title of Class of Securities:  Common Stock CUSIP Number:  717081103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on the following page(s))     13G CUSIP No.:  717081103 1.  NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Vanguard Group - 23-1945930 2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP A.  B.  X 3.  SEC USE ONLY 4.  CITIZENSHIP OF PLACE OF ORGANIZATION Pennsylvania (For questions 5-8, report the number of shares beneficially owned by each reporting person with:) 5.  SOLE VOTING POWER 0 6.  SHARED VOTING POWER 7,098,817 7.  SOLE DISPOSITIVE POWER 481,625,108 8.  SHARED DISPOSITIVE POWER 24,854,699 9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 506,479,807 10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.97% 12.  TYPE OF REPORTING PERSON IA     SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Act of 1934 Item 1(a) - Name of Issuer: Pfizer Inc Item 1(b) - Address of Issuer's Principal Executive Offices: 66 Hudson Boulevard East New York, NY 10001-2192 Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930 Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355 Item 2(c) – Citizenship: Pennsylvania Item 2(d) - Title of Class of Securities:

View on Read The Filing